Another settlement. Another press release. Another promise that lessons have been learned.
For Centene Corporation, fines related to Medicaid practices have become a familiar cost of doing business. Over the years, the company has paid billions to resolve allegations involving billing practices, pharmacy benefit management, enrollment errors, and compliance failures. Yet across states and programs, the same operational problems continue to surface.
The reason is simple. Settlements punish outcomes without changing incentives. They close cases without correcting the structures that caused them.
Settlements That End Cases, Not Conduct
Most Medicaid settlements follow a predictable pattern. Investigations stretch on for years. Evidence accumulates. Negotiations conclude with a large payment and no admission of wrongdoing. The company agrees to enhanced monitoring, temporary reporting obligations, or internal reviews.
What rarely changes is how the business actually operates.
The contracts remain intact. Leadership remains in place. Revenue continues to flow. The settlement resolves legal exposure but leaves the core model untouched.
From a corporate perspective, this approach works. From a public health perspective, it fails.
Why Fines Do Not Deter Behavior
For a company of Centene’s size, even billion dollar settlements are manageable. They are booked as one time expenses. Investors are reassured. Earnings guidance adjusts. Operations move forward.
What fines do not do is alter the financial calculus that rewards cost containment through delay, denial, and administrative friction. As long as profits generated through aggressive utilization controls exceed the cost of penalties, the behavior remains rational.
This is not speculation. It is how risk is priced.
Structural Problems Go Unaddressed
The recurring issues cited in settlements often point to the same underlying practices. Narrow networks that exist on paper but not in practice. Pharmacy pricing mechanisms that lack transparency. Claims systems that delay or reduce payments. Enrollment processes that shift risk onto patients and providers.
These are not isolated errors. They are structural features of a model designed to manage public programs at scale while protecting margins.
Settlements focus on specific violations. They do not dismantle the architecture that enables them.
Monitoring Without Consequences
Post settlement oversight is frequently limited in scope and duration. Compliance plans rely on internal reporting. Audits are scheduled and anticipated. Penalties for future violations are often capped or conditional.
In practice, monitoring becomes a box checking exercise. Once the agreement expires, scrutiny fades. The system reverts.
For states that depend on large managed care organizations to administer Medicaid, the leverage to demand deeper reform is weak. Replacing a contractor of Centene’s size is complex, risky, and politically fraught.
Patients and Providers Pay the Price
While settlements are announced in headlines, their benefits rarely reach patients or providers.
There are no automatic rate increases for underpaid clinicians. No restored networks in rural counties. No reduction in prior authorization burdens. No meaningful improvement in payment timelines.
Providers continue to exit. Patients continue to wait. Complaints continue to rise.
The settlement closes a legal chapter but leaves the lived experience unchanged.
A System That Absorbs Penalties
Centene operates in an environment where accountability is fragmented. Federal agencies, state regulators, and private contractors share responsibility. Each settlement addresses a slice of conduct without confronting the whole.
This fragmentation allows large organizations to absorb penalties while maintaining their market position. Contracts are renewed. New states are added. Growth continues.
In effect, the system trains companies to manage legal risk rather than fix operational harm.
What Would Actually Change Behavior
If fines were tied to contract eligibility, executive compensation, or market access, they would matter. If repeated violations triggered automatic contract termination or state takeovers, incentives would shift.
Transparency requirements that expose internal pricing, denial patterns, and network performance would force accountability beyond legal settlements.
Most importantly, enforcement would need to focus on access and outcomes, not just billing compliance.
The Cost of Doing Nothing Different
Every time a settlement is announced without structural reform, the message is reinforced. The problem is not serious enough to require change.
For Centene, fines remain manageable. For patients and providers, the consequences accumulate.
Until accountability reaches beyond financial penalties and into how Medicaid is actually managed, the cycle will continue. Another investigation. Another settlement. The same problems, intact.
